skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > organooxygen compound > sphingolipid > glycosphingolipid > neolacto-series glycosphingolipid > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > glycohexaosylceramide > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > glycohexaosylceramide > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycohexaosylceramide > n-acetyl-alpha-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-ceramide > n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine

اصطلاح مرجح

n-acetyl-alpha-d-galactosaminyl-(1->3)-[alpha-l-fucosyl-(1->2)]-beta-d-galactosyl-(1->4)-n-acetyl-beta-d-glucosaminyl-(1->3)-beta-d-galactosyl-(1->4)-beta-d-glucosyl-(1<->1')-n-acylsphinganine  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

شناسه-آلت

  • CHEBI:144423

بار

  • 0

فرمول

  • C59H104N3O32R

جرم

  • 1367.460

جرم تک‌ایزوتوپی

  • 1366.66029

اسمایلٓ

  • CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O[C@H]5O[C@H](CO)[C@H](O)[C@H](O)[C@H]5NC(C)=O)[C@H]4O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H](O)[C@H]3NC(C)=O)[C@H]2O)[C@H](O)[C@H]1O)NC([*])=O

زیرمجموعه

  • 3_STAR

مترادف دقیق

  • N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acylsphinganine

مترادف مرتبط

  • alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(d18:0)
  • alpha-D-GalNAc-(1->3)-[alpha-L-Fuc-(1->2)]-beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-Cer(d18:0)
  • alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-Cer(d18:0)
  • a neolactoside IV(3)-alpha-GalNAc,IV(2)-alpha-Fuc-nLc4Cer(d18:0)
  • blood antigen group A type II(d18:0)
  • N-acetyl-alpha-D-galactosaminyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-dihydroceramide

در زبان های دیگر

  • N.

    Persian

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:91118

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD